Moriuchi, K.; Kawasaki, K.; Hayashi, M.; Ueda, A.; Yamanishi, Y.; Mogami, H.; Fujita, K.; Shiro, R.; Yo, Y.; Mandai, M.;
et al. Plasma Antithrombin Activity during Long-Term Magnesium Sulfate Administration for Preeclampsia without Severe Hypertension. Healthcare 2022, 10, 1581.
https://doi.org/10.3390/healthcare10081581
AMA Style
Moriuchi K, Kawasaki K, Hayashi M, Ueda A, Yamanishi Y, Mogami H, Fujita K, Shiro R, Yo Y, Mandai M,
et al. Plasma Antithrombin Activity during Long-Term Magnesium Sulfate Administration for Preeclampsia without Severe Hypertension. Healthcare. 2022; 10(8):1581.
https://doi.org/10.3390/healthcare10081581
Chicago/Turabian Style
Moriuchi, Kaori, Kaoru Kawasaki, Maako Hayashi, Akihiko Ueda, Yukio Yamanishi, Haruta Mogami, Kohei Fujita, Reona Shiro, Yoshie Yo, Masaki Mandai,
and et al. 2022. "Plasma Antithrombin Activity during Long-Term Magnesium Sulfate Administration for Preeclampsia without Severe Hypertension" Healthcare 10, no. 8: 1581.
https://doi.org/10.3390/healthcare10081581
APA Style
Moriuchi, K., Kawasaki, K., Hayashi, M., Ueda, A., Yamanishi, Y., Mogami, H., Fujita, K., Shiro, R., Yo, Y., Mandai, M., & Matsumura, N.
(2022). Plasma Antithrombin Activity during Long-Term Magnesium Sulfate Administration for Preeclampsia without Severe Hypertension. Healthcare, 10(8), 1581.
https://doi.org/10.3390/healthcare10081581